CompletedNCT03872310
Official study titleA Study of Cognitive Enhancement of Transcranial Direct Current Stimulation on Working Memory in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaDevice studyAges 20–55
- Countries
- Taiwan
- Sponsor
- Taipei Medical University Shuang Ho Hospital
UnknownNCT06482918
Official study titleCognitive Remediation in Schizophrenia Patients: Study of the Efficacy and of the Role of Neuroplasticity in Two Different Approaches Based on "Top-down" and "Bottom-up" Mechanisms
Current recruitment status is unconfirmed.
In SantiagoSchizophreniaBehavioural studyAges 18–59
- Countries
- Chile
- Sponsor
- University of Chile
CompletedNCT02864576
Official study titleCognitive Remediation Plus Aerobic Exercise in Schizophrenia Treatment: a Randomized Controlled Study.
This study has finished and is no longer accepting participants.
In BarcelonaSchizophreniaBehavioural studyAges 28–60
- Countries
- Spain
- Sponsor
- Parc de Salut Mar
WithdrawnNCT03497299
This study was withdrawn before enrollment.
Location not clearly listedSchizophrenia, AddictionDevice studyAges 18–55
- Countries
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT06572657
Official study titleComparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizophrenia - A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In IstanbulSchizophreniaInterventional studyAges 20–60
- Countries
- Türkiye
- Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
CompletedNCT07173465
Official study titleComparison of the Effects of Physical Activity and Virtual Reality Training on Physical Function, Cognition and Quality of Life in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In IstanbulSchizophreniaDevice studyAges 20–77
- Countries
- Türkiye
- Sponsor
- Yeditepe University
CompletedNCT00554840
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–64
- Countries
- Sponsor
- University of Maryland, Baltimore
CompletedNCT03183609
Official study titleConfirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)
This study has finished and is no longer accepting participants.
In CatonsvilleSchizophreniaPlacebo comparisonAges 18–64
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
CompletedNCT02287584
Official study titleConfirmatory Study of DSP-5423P in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Beijing, Etc.SchizophreniaMedication studyAges 18+
- Countries
- China, Japan, Malaysia, + 5 others
- Sponsor
- Sumitomo Pharma Co., Ltd.
CompletedNCT04860830
What is this study about?Researchers compared Iclepertin and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–50
- Countries
- United States, United Kingdom, Belgium, + 15 others
- Sponsor
- Boehringer Ingelheim
TerminatedNCT06397950
This study ended early.
In La CrauSchizophreniaObservational studyAges 18+
- Countries
- France
- Sponsor
- GCS CIPS
CompletedNCT02879604
This study has finished and is no longer accepting participants.
Multiple locations, including BordeauxSchizophreniaPlacebo comparisonAges 18–60
- Countries
- France
- Sponsor
- University Hospital, Montpellier